Anti-B7-H1 and anti-CTLA-4 antibodies for treating non-small cell lung cancer

摘要

Provided herein are methods of treating non-small cell lung cancers comprising administering an effective amount of MEDI4736 or an antigen-binding fragment thereof and tremelimumab or an antigen- binding fragment thereof.